scholarly journals Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

2019 ◽  
Vol 178 (2) ◽  
pp. 251-261
Author(s):  
Zhe-Bin Liu ◽  
Nader E. Ezzedine ◽  
Agda K. Eterovic ◽  
Joe E. Ensor ◽  
Helen J. Huang ◽  
...  
2015 ◽  
Author(s):  
Kathy S Albain ◽  
Andrei Y Zlobin ◽  
Kyle R Covington ◽  
Brian T Gallahger ◽  
Susan G Hilsenbeck ◽  
...  

2016 ◽  
pp. 431 ◽  
Author(s):  
Kongming Wu ◽  
Hanxiao Xu ◽  
Xun Yuan ◽  
Yijun Tian ◽  
Yu Liu ◽  
...  

2015 ◽  
Author(s):  
Jing Yang ◽  
Adam Engler ◽  
Laurent Fattet ◽  
Matthew Ondeck

2020 ◽  
Vol 26 (61) ◽  
pp. 14011-14017
Author(s):  
Catherine J. Feld ◽  
Alice Johnson ◽  
Zhiyin Xiao ◽  
Kogularamanan Suntharalingam

2021 ◽  
Vol Volume 16 ◽  
pp. 1487-1508
Author(s):  
Li Lv ◽  
Yonghui Shi ◽  
Junyan Wu ◽  
Guocheng Li

2021 ◽  
Vol 11 ◽  
Author(s):  
Hongzhi Wang ◽  
Hanjiang Xu ◽  
Quan Cheng ◽  
Chaozhao Liang

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and is characterized by high rates of metastasis. Cancer stem cell is a vital cause of renal cancer metastasis and recurrence. However, little is known regarding the change and the roles of stem cells during the development of renal cancer. To clarify this problem, we developed a novel stem cell clustering strategy. Based on The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) genomic datasets, we used 19 stem cell gene sets to classify each dataset. A machine learning method was used to perform the classification. We classified ccRCC into three subtypes—stem cell activated (SC-A), stem cell dormant (SC-D), and stem cell excluded (SC-E)—based on the expressions of stem cell-related genes. Compared with the other subtypes, C2(SC-A) had the highest degree of cancer stem cell concentration, the highest level of immune cell infiltration, a distinct mutation landscape, and the worst prognosis. Moreover, drug sensitivity analysis revealed that subgroup C2(SC-A) had the highest sensitivity to immunotherapy CTLA-4 blockade and the vascular endothelial growth factor receptor (VEGFR) inhibitor sunitinib. The identification of ccRCC subtypes based on cancer stem cell gene sets demonstrated the heterogeneity of ccRCC and provided a new strategy for its treatment.


Author(s):  
Makiko Ono ◽  
Yasuhiro Fujiwara ◽  
Takahiro Ochiya

Sign in / Sign up

Export Citation Format

Share Document